Visby Medical, a San Jose, CA-based at-home polymerase chain response (PCR) diagnostics firm, raised roughly $55M in funding.
The spherical was led by Catalio Capital Administration, with participation from current buyers together with ND Capital, Cedars Sinai Medical Heart, Blue Water Life Science Advisors, Pitango Ventures and John Doerr.
As a part of the funding spherical, Catalio Associate Isaac Ro, joins Visby Medical’s board as an observer.
The corporate intends to make use of the funds to speed up the launch and distribution of its lately FDA-authorized at-home ladies’s sexual well being check.
Based by CEO Adam de la Zerda, Visby Medical improves the infectious illness prognosis by empowering each physicians and sufferers to precisely check for infections with laboratory accuracy. Its proprietary know-how platform delivers true PCR leads to beneath half-hour via instrument-free, single-use PCR checks that match within the palm of a hand.
At present, the corporate presents FDA-cleared checks for sexually transmitted infections (STIs), out there each in point-of-care settings and now on to shoppers at residence, and respiratory infections (COVID-19, flu A and flu B), out there for point-of-care settings.
The elevate introduced the entire quantity as much as $65M.
FinSMEs
19/06/2025
